Search

everythinglearnresearchcommunity

for

Search:↓

The revised European Patent Convention may limit generic drug use, affecting healthcare professionals' treatment choices.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

Abolishing medical indication patents could hinder innovation in medicine.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Using finasteride with TIP extends time off period for prostate cancer patients.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Pharmacy workers need more education to better help people with hair loss.

New patents include innovations in skin and hair care, disease treatment, plant stress tolerance, and protein purification.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Nanostructured lipid carriers are promising for improving drug delivery in medicine and food.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Vitamin D3 is crucial for immune and bone health, with most consumers being women who follow doctor advice.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Copaiba resin oil shows promise for cancer therapy and is safe for topical use.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Medication and hair removal methods can improve hirsutism, but no drugs were specifically approved for it in North America as of 1995.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

Pharmacists play a key role in helping patients use over-the-counter products correctly, including those for hair regrowth and smoking cessation.

Melatonin vitamin C-based nanovesicles improved hair growth and reduced hair loss in androgenic alopecia patients.

Pharmaceutical ads for Rogaine and Accutane may be misleading and not financially sensible.

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.